Clinical Trial Update: Study of PF-07265807 in Participants With Metastatic Solid Tumors. [Phase 1]

View source ↗

Summary

A Phase 1 study of PF-07265807 in participants with metastatic solid tumors was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PF-07265807

Snippet

Sponsor: Pfizer | Conditions: Neoplasm Metastasis | Phase 1 | Status: TERMINATED